Nutrition, Physical Performance & Fitness in Indian School Children
Trial overview
Change from baseline in maximal aerobic capacity (VO2max)- 12 inch step test after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in aerobic capacity-shuttle test (VO2peak) after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in time taken for 40 meter (m) sprint after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in visual reaction time after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in maximal handgrip strength for dominant and non-dominant hand after 4 Months
Timeframe: Baseline, after 4 months
Change from baseline in time to fatigue after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in rate of decline of muscle strength after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in hemoglobin level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in Ferritin level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in soluble transferring receptors (sTr) after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in C-reactive protein level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in Vitamin B2 level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in Vitamin B6 level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in Vitamin B12 level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in folate level after 4 months
Timeframe: Baseline, after 4 months
Change from baseline in Vitamin C level after 4 months
Timeframe: Baseline, after 4 months
- Boys and girls between ages 7-10.5 years
- Z score of height for age and weight for age of 0 to < -3
- Severe anemia (Hb<8 g% )
- Cardiovascular disease on clinical examination or history
- Boys and girls between ages 7-10.5 years
- Z score of height for age and weight for age of 0 to < -3
- Good general health at screening
- Understands and is willing, able and likely to comply with all study procedures and restrictions
- Written informed consent from the parents/ guardians and writtent assent by the study participant
- Severe anemia (Hb<8 g% )
- Cardiovascular disease on clinical examination or history
- Any underlying respiratory disease with impairment of lung function
- Physical disability Children consuming nutritional supplements (tonics, syrups, tablets or chews) and/ or health food drinks on a regular basis
- Recent history [3mo] of serious infections, injuries and/ or surgeries
- Participation in any nutritional study in the last 1 year
- Indication that they are likely to move within the period of study intervention
- Any known food allergies like peanut allergy, gluten allergy
- Family members of an employee of the Sponsor or the study site.
Trial location(s)
Study documents
No study documents available.
Results overview
Results posted on ClinicalTrials.gov
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.